Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Manjit Matharu
manjit.matharu@ucl.ac.uk


Manjit Matharu
manjit.matharu@ucl.ac.uk


Study Location:

Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - Craniocervical imaging in joint hypermobility disorders (version 1)

Craniocervical imaging in joint hypermobility disorders (version 1)

Recruiting

Open to: Female / Male

Age: 18 Years - N/A

Medical Conditions

Congenital malformations and deformations of the musculoskeletal system
Systemic connective tissue disorders
General symptoms and signs


This information is provided directly by researchers and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information.


People with joint hypermobility disorders, including hypermobile Ehlers-Danlos syndrome (hEDS) and hypermobility spectrum disorder, frequently suffer from headaches, neck pain and other neurological symptoms. However, the cause of these symptoms is poorly understood. Hypermobility of the craniocervical junction has been proposed as a major cause of these symptoms, termed cervicomedullary syndrome (CMS). It is purported that this can be diagnosed by upright dynamic magnetic resonance imaging (MRI) and treated by craniocervial fixation surgery, however this imaging technique is yet to be validated.

We plan to perform an upright dynamic MRI in three equal groups of 40 participants (120 in total): 1. Healthy controls without joint hypermobility or symptoms of CMS; 2. people with joint hypermobility disorder (either hypermobile EDS or hypermobility spectrum disorder) according to published criteria but no symptoms of CMS; and 3. Joint hypermobility disorder (either hypermobile EDS or hypermobility spectrum disorder) who have symptoms of CMS. We will record the presence of craniocervical junction abnormalities and radiological measurements of hypermobility.

We will be the first group to establish normative ranges for the assessment of the craniocervical junction on upright dynamic MRI. We will be able to show to what degree this region of the body differs in people with joint hypermobility disorders compared to healthy controls. By comparing people with hEDS with and without symptoms of CMS we can study which imaging abnormalities are most related to symptoms.

The main hypothesis of this study is that craniocervical hypermobility in patients with joint hypermobility disorders would cause structural brainstem or spinal cord damage. If our results were in line with this hypothesis, then we would provide evidence supporting larger surgical trials that will help to deliver improved care to highly disabled patients. Alternatively, we would provide data against potentially unnecessary invasive and expensive neurosurgical treatment.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

23 Feb 2023 30 Jun 2025

Observational

Observational type: Cross-sectional;



You can take part if:



You may not be able to take part if:


1. Previous cranial or cervical spine surgery 2. Any contraindication to MR imaging 3. Inability to understand study information in order to provide consent: this may include those with cognitive impairment or language barrier


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • National Hospital For Neurology & Neurosurgery - Queen Square
    London
    Greater London
    WC1N 3BG

Manjit Matharu
manjit.matharu@ucl.ac.uk


Manjit Matharu
manjit.matharu@ucl.ac.uk



The study is sponsored by University College London and funded by The Ehlers-Danlos Society .




We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?

Read full details

for Trial ID: CPMS 52621

Last updated 21 November 2024

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.